1. All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival. (10th February 2016) Authors: Arese, D.; Martini, S.; Sacco, M.; Strona, S.; Cocchis, D.; Mirabella, S.; Rizza, G.; Ottobrelli, A.; Torrani-Cerenzia, M.R.; Balzola, F.; Magistroni, P.; Moschini, P.; Amoroso, A.; Salizzoni, M.; Rizzetto, M.; Romagnoli, R.; Saracco, G.M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗